Key result
Higher serum ET-2 is linked to ~4% lower odds of unstable carotid plaque.
Why the study?
Carotid plaque instability is an important determinant of stroke risk, but circulating non-invasive biomarkers of plaque vulnerability such as endothelin-2 and endothelin-3 remain limited.
Does measurement of circulating endothelin-2 and endothelin-3 accurately discriminate between stable and unstable plaque phenotypes in patients undergoing carotid endarterectomy?
Case-Control (n=88)
Does measurement of circulating endothelin-2 and endothelin-3 accurately discriminate between stable and unstable plaque phenotypes in patients undergoing carotid endarterectomy?
Lower circulating ET-2 and ET-3 concentrations are independently associated with carotid plaque instability and show high discriminatory accuracy as potential non-invasive biomarkers in patients undergoing carotid endarterectomy.
ET-2 and ET-3 may indicate carotid plaque instability; leaves open their value as biomarkers until validated in larger prospective cohorts.
Background: Carotid plaque instability is an important determinant of stroke risk, but circulating biomarkers of plaque vulnerability remain limited. This study aimed to investigate circulating endothelin 2 (ET-2) and endothelin 3 (ET-3) as potential non-invasive biomarkers of plaque instability in patients with carotid atherosclerosis. Methods: Serum ET-2 and ET-3 concentrations were measured in 76 patients undergoing carotid endarterectomy (40 with stable and 36 with unstable plaque phenotypes) and in 12 control subjects without carotid atherosclerosis. Endothelin receptor A (ETA) and endothelin receptor B (ETB) expression within carotid plaques were also assessed. The discriminatory performance of endothelins for distinguishing stable from unstable plaque phenotypes was evaluated using receiver operating characteristic (ROC) analysis, and logistic regression analyses were performed to identify factors associated with plaque instability. Results: Serum ET-2 and ET-3 concentrations were lower in patients with stable plaque phenotype than in controls, and were further reduced in patients with unstable phenotype. Both endothelins showed good discrimination between unstable and stable plaque phenotypes (AUCs 0.847 and 0.817, respectively; both p < 0.0001). In univariable logistic regression, both ET-2 and ET-3 were significantly associated with unstable plaque phenotype. These associations remained significant after adjustment for clinical confounders in separate multivariable models (ET-2: OR 0.963, p < 0.0001; ET-3: OR 0.971, p = 0.001). ETA receptor expression was higher in unstable than stable plaques, whereas ETB expression did not differ significantly. Conclusions: Circulating ET-2 and ET-3 concentrations may represent promising candidates for non-invasive assessment of carotid plaque phenotype but their diagnostic performance requires further validation in larger and independent cohorts.
No takes yet. Share an insight, caveat, or question.
Płoński et al. (2026) conducted a case-control in Carotid atherosclerosis / carotid plaque instability (n=88). Circulating serum endothelin-2 (ET-2) and endothelin-3 (ET-3) concentrations vs. Stable carotid plaque phenotype and control subjects without carotid atherosclerosis was evaluated on Unstable carotid plaque phenotype (OR 0.963, p=< 0.0001). Serum ET-2 and ET-3 concentrations discriminated unstable from stable carotid plaques (AUCs 0.847 and 0.817; p<0.0001) and associated with instability (OR 0.963 and 0.971).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: